PRTA - Prothena Corporation Qarzning balans kapitallashuviga nisbati

Prothena Biosciences (PRTA) tovar belgisi

Prothena Corporation (PRTA) terapevtik molekulalarni tanlashni tezlashtirish uchun avtomatlashtirilgan laboratoriya tizimlarini joriy qilmoqda. Prothena Corporation (PRTA) ning moliyaviy holati klinik sinovlar xarajatlari tufayli beqaror pul oqimi bilan tavsiflanadi va joriy ko'rsatkich 0.02 ni tashkil etadi. Quyida ko'rsatilgan narxlar tendentsiyasi aktivning bozor dinamikasini vizuallashtiradi. Yuqori rahbariyatning strategiyasi nerv hujayralari degeneratsiyasiga qarshi dori vositalarini ishlab chiqish xarajatlarini optimallashtirish uchun sog'liqni saqlash gigantlari bilan hamkorlik qilishga asoslanadi.

Prothena Corporation PLC (PRTA) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Prothena Corporation (PRTA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Prothena Corp|PRTA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Prothena Biosciences|PRTA - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Prothena|PRTA - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati prothena.com|PRTA - Kompaniya aktivlarining umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Prothena Corporation|PRTA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati prothena.com|PRTA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Prothena Biosciences
Kompaniyaning barcha koʻrsatkichlari tahlili:PRTA Prothena Corporation plc
prothena.com asosiy tovari

Ushbu ko'rsatkich Prothena Corporation (PRTA) moliyaviy barqarorligini baholaydi hamda qarz mablag'lariga bog'liqlik darajasini aniqlash uchun umumiy majburiyatlarni kapital bilan solishtiradi. Kompaniyaning umumiy qarzi va uning balans kapitali nisbatini tahlil qilish orqali, investor eksklyuziv molekulalardan monopol daromadlar olishdan oldin bankrotlik xavfisiz, neyrodegenerativ kasalliklar uchun dori vositalarini qimmatga ishlab chiqishni moliyalashtirish bo'yicha ushbu biotexnologiya startapining qobiliyatini baholashi mumkin.

Prothena Corporation raqobatchilari

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Viking Therapeutics VKTX|Qarzlarning balans kapitallashuviga nisbati SUPN|Catalyst Pharmaceuticals, Inc. (CPRX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati DNLI (Denali)|HRMY: Qarzning balans kapitallashuviga nisbati|BHVN - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amylyx Pharmaceuticals AMLX|TRVI - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Praxis Precision Medicines, Inc. PRAX|Anavex (AVXL) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CBLL (CeriBell Corp)|Balans qiymatiga qarzlar ALEC|Qarzning balans kapitallashuviga nisbati Annexon, Inc. ANNX|Qarzning balans qiymatiga nisbati omeros.com (OMER)|Balans kapitallashuviga qarzlar NGNE (Neurogene)|ACIU - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Voyager Pharma (VYGR)|NMRA - Qarzning sof aktivlarga nisbati|SCLX (Scilex Holding Company) - Balans kapitallashuviga qarzlar|TVGN (tevogen.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ACOG (Alpha Cognition Inc)|Balans qiymatiga qarzlar CGTX|Inhibikase (IKT) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SAVA (Cassava Pharma)|Assertio (ASRT) - Qarzning balans kapitallashuviga nisbati|Coya Therapeutics Inc - Qarzlarning balans kapitallashuviga nisbati|VTGN (VistaGen Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|OVID: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Acumen Pharma ABOS|CervoMed Corporation (CRVO) - Qarzning sof aktivlarga nisbati|ATHE (Alterity Therapeutics Ltd.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Clene Nanomedicine (CLNN)|Qarzning balans qiymatiga nisbati PepGen Inc.|Qarzning balans kapitaliga nisbati Jupiter Neurosciences, Inc. (JUNS)|Balans kapitallashuviga qarzlar RLMD|Annovis Bio Corporation - Sof aktivlarga qarzlar|GRCE (Grace Tx) - Qarzning balans kapitallashuviga nisbati|AIFF: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati anewmeds.com|NRSN (NeuroSense Therapeutics Ltd.) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings RVPH|Qarzlarning balans kapitallashuviga nisbati MTVA|NeurAxis, Inc. (NRXS) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati heliusmedical.com HSDT|Qarzning balans qiymatiga nisbati Passage Bio (PASG)|Qarzning balans kapitaliga nisbati Neuphoria Therapeutics, Inc. NEUP|Minerva Neurosciences Corp - Balans kapitallashuviga qarzlar|ATHA: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Addex Therapeutics|Alzamend Neuro (ALZN) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CYCN (Cyclerion Therapeutics Inc.)|Balans qiymatiga qarzlar Protagenic (PTIX)|Qarzning balans qiymatiga nisbati KTTA|Balans kapitallashuviga qarzlar CRGT (cortigent.com)|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics|brainstorm-cell.com - Qarzning sof aktivlarga nisbati|CARA (Cara Therapeutics) - Qarzning balans kapitallashuviga nisbati|CHRO: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati eliemtx.com (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Qarzlarning balans kapitallashuviga nisbati|LBPH - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati MRNS|NKGen Biotech - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar NeuroBo Pharmaceuticals Inc NRBO|Qarzning balans qiymatiga nisbati Sage Therapeutics, Inc (SAGE)|Qarzning balans kapitaliga nisbati Synaptogenix, Inc SNPX|Balans kapitallashuviga qarzlar Trevena, Inc. (TRVN)|VIGL - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar WENA|CERE (Cerevel Therapeutics Inc) - Balans qiymatiga qarzlar